Edition:
United Kingdom

Alder Biopharmaceuticals Inc (ALDR.OQ)

ALDR.OQ on NASDAQ Stock Exchange Global Market

11.05USD
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
$11.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
240,072
52-wk High
$25.40
52-wk Low
$8.68

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Stephen Dow

61 2005 Independent Chairman of the Board

Randall Schatzman

62 2004 President, Chief Executive Officer, Director

Larry Benedict

56 2016 Executive Vice President, Principal Accounting Officer

James Bucher

51 2016 Senior Vice President, General Counsel

Randal Hassler

59 2014 Senior Vice President - Pharmaceutical Operations